Skip to main content
Fig. 12 | Lipids in Health and Disease

Fig. 12

From: 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters

Fig. 12

Expression of EGFR protein in whole lysates of MDA-MB-231 cells after treatment with 4-cholesten-3-one. Cells were treated or not for 24 and 48 h with 75 μM 4-cholesten-3-one. Western blot analysis was then performed to detect EGFR and beta-actin (loading control) in breast cancer cell lysates treated (+) or not treated (−)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X